Pulmonary Embolism (PE) Therapeutics Pipeline Assessment and Market Forecasts to
Browse Full Report @
Published: Feb 2012 | No. Of Pages: 88 Pages
PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
The industry analysis specialist, has released its new report, “Pulmonary Embolism (PE) Therapeutics Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and
analysis on the global Pulmonary Embolism Therapeutics market. The report identifies the key trends shaping and
driving the global Pulmonary Embolism Therapeutics market. The report also provides insights on the prevalent
competitive landscape and the emerging players expected to significantly alter the market positioning of the
current market leaders. Most importantly, the report provides valuable insights on the pipeline products within
the global Pulmonary Embolism Therapeutics sector. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry
The report provides information on the key drivers and challenges of the Pulmonary Embolism Therapeutics
market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Pulmonary Embolism
Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and
emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
Website : http://www.aarkstore.com/
- Analysis of the current and future competition in the seven key countries Pulmonary...